The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Abstract
Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies can estimate the extent of CMV “obsession” by identifying antigen-specific cells using peptide-MHC class-I or class-II multimers (Altman et al. 1996; Davis et al. 2011).”
From Is immunosenescence influenced by our lifetime “dose” of exercise? (2016) · cites this paper as Altman et al. 1996
Citations
Cites
Handbook of Experimental Immunology.
Denman, A. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1376_1 · Cited by 2,414
HANDBOOK OF EXPERIMENTAL IMMUNOLOGY
Holborow, E. J. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.4.534-c · Cited by 678
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 671
Schatz, P. J. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1138 · Cited by 585
Antigen-Specific Development of Primary and Memory T Cells in Vivo
McHeyzer‐Williams, M. G., & Davis, M. M. (1995) · Science · doi:10.1126/science.7535476 · Cited by 439
Self-citationKo, H. S., Fu, S. M., WINCHESTER, R. J., Yu, D. T. Y., & Kunkel, H. G. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.150.2.246 · Cited by 439
Nixon, D. F., Townsend, A., Elvin, J. G., Rizza, C. R., Gallwey, J., & McMichael, A. J. (1988) · Nature · doi:10.1038/336484a0 · Cited by 431
Self-citationMatsui, K., Boniface, J. J., Steffner, P., Reay, P. A., & Davis, M. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12862 · Cited by 425
Self-citationCarmichael, A. J., Jin, X., Sissons, P., & Borysiewicz, L. K. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.249 · Cited by 418
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
Hoffenbach, A., Langlade‐Demoyen, P., Dadaglio, G., VILMER, E., Michel, F., Mayaud, C. M., Autran, B., & Plata, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.452 · Cited by 304
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Hayakawa K., Ishii R., Yamasaki K., Kishimoto T., Hardy R. R., ibid. 84, 1379 (1987);
- Schatz P. J., Biotechnology 11, 1138 (1993).
- Johnson R. P., et al., ibid. 147, 1512 (1991).
- Koup R. A., et al., ibid. 174, 1593 (1991).
- Tripp R. A., Hou S., Doherty P. C., ibid. 154, 5870 (1995);
Cited by
Sorted by citations
Items 401–500 of 1,007
Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV
Kuijpers, T. W., Vossen, M. T. M., Gent, M.-R., Davin, J. C., Roos, M. T. L., Dillen, P. M. E. W., Weel, J. F. L., Baars, P. A., & van Lier, R. A. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4342 · Cited by 169
van Baarle, D., Hovenkamp, E., Callan, M. F. C., Wolthers, K. C., Kostense, S., Tan, L., Niesters, H. G. M., Osterhaus, A. D. M. E., McMichael, A. J., van Oers, M. H. J., et al. (2001) · Blood · doi:10.1182/blood.v98.1.146 · Cited by 169
Self-citationPan-Peptide Meta Learning for T-cell receptor–antigen binding recognition
Gao, Y., Gao, Y., Fan, Y., Zhu, C., Wei, Z., Zhou, C., Chuai, G., Chen, Q., Zhang, H., & Liu, Q. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00619-3 · Cited by 155
Hirano, N., Butler, M. O., Xia, Z., Ansén, S., von Bergwelt‐Baildon, M. S., Neuberg, D. S., Freeman, G. J., & Nadler, L. M. (2005) · Blood · doi:10.1182/blood-2005-05-2073 · Cited by 173
Ressing, M. E., van Driel, W. J., Brandt, R. M. P., Kenter, G. G., de Jong, J. H., Bauknecht, T., Fleuren, G. J., Hoogerhout, P., Offringa, R., Sette, A., et al. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200003000-00010 · Cited by 167
“A newly developed approach based on T-cell receptor interaction with antigenic complexes in the form of tetramers (41) may allow detection of low numbers of (viral) peptide-specific CTLs.”
MethodWooldridge, L., van den Berg, H. A., Glick, M., Emma Gostick, D., Laugel, B., Hutchinson, S., Milicic, A., Brenchley, J. M., Douek, D. C., Price, D. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500555200 · Cited by 168
Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL
Chen, J., Dunbar, P. R., Gileadi, U., Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Panicali, D., Chen, Y., Knuth, A. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.948 · Cited by 168
Rezvani, K., Yong, A. S. M., Savani, B. N., Mielke, S., Keyvanfar, K., Emma Gostick, D., Price, D. A., Douek, D. C., & Barrett, A. J. (2007) · Blood · doi:10.1182/blood-2007-03-076844 · Cited by 167
Wills, M. R., Carmichael, A., Weekes, M. P., Mynard, K., Okecha, G., Hicks, R., & Sissons, J. G. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7080 · Cited by 167
Three Memory Subsets of Human CD8+ T Cells Differently Expressing Three Cytolytic Effector Molecules
Takata, H., & Takiguchi, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4330 · Cited by 166
“HLA class I-peptide tetrameric complexes (tetramers) were synthesized, as previously described (18).”
MethodPeptide–MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
Singha, S., Shao, K., Yang, Y., Clemente‐Casares, X., Solé, P., Clemente, A., Blanco, J., Dai, Q., Song, F., Liu, S. W., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.56 · Cited by 166
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis
Sheehy, M. E., McDermott, A. B., Furlan, S. N., Klenerman, P., & Nixon, D. F. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00329-x · Cited by 166
Thimme, R., Appay, V., Koschella, M., Panther, E., Roth, E., Hislop, A. D., Rickinson, A. B., Rowland‐Jones, S., Blum, H. E., & Pircher, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.12112-12116.2005 · Cited by 163
“The tetramers were prepared by us as described previously (1).”
MethodTransregulation of memory CD8 T-cell proliferation by IL-15Rα+ bone marrow–derived cells
Schluns, K. S., Klonowski, K. D., & Lefrançois, L. (2003) · Blood · doi:10.1182/blood-2003-08-2814 · Cited by 165
Cooper, L. J. N., Kalos, M. D., Lewinsohn, D. A., Riddell, S. R., & Greenberg, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8207-8212.2000 · Cited by 165
“It is often difficult to isolate CTL from individuals with advanced disease with expended CTL responses (10), as well as individuals receiving prolonged therapy with highly active antiretroviral therapy, due to the fall in precursor frequency of CTL to HIV following the reduction in viral burden (2).”
BackgroundMolldrem, J. J., Lee, P. P., Wang, C., Champlin, R. E., & Davis, M. M. (1999) · PubMed · Cited by 165
Self-citationStrategies for immunotherapy of cancer
Melief, C. J. M., Toes, R. E. M., Medema, J. P., van der Burg, S. H., OSSENDORP, F. A., & Offringa, R. (2000) · Advances in immunology · doi:10.1016/s0065-2776(00)75006-1 · Cited by 167
Increased CD95/Fas-Induced Apoptosis of HIV-Specific CD8+ T Cells
Mueller, Y. M., De Rosa, S. C., Hutton, J. A., Witek, J., Roederer, M., Altman, J. D., & Katsikis, P. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00246-1 · Cited by 164
Self-citationMallajosyula, V. V. A., Ganjavi, C., Chakraborty, S., McSween, A. M., Pavlovitch-Bedzyk, A. J., Wilhelmy, J., Nau, A. N., Manohar, M., Nadeau, K. C., & Davis, M. M. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg5669 · Cited by 168
Self-citationRomero, P. J., Valmori, D., Pittet, M. J., Zippelius, A., Rimoldi, D., Lévy, F., Dutoit, V., Ayyoub, M., Rubio‐Godoy, V., Michielin, O. A., et al. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18808.x · Cited by 166
Barouch, D. H., Kunstman, J., Glowczwskie, J., Kunstman, K., Egan, M. A., Peyerl, F. W., Santra, S., Kuroda, M. J., Schmitz, J. E., Beaudry, K. R., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7367-7375.2003 · Cited by 164
“antibodies to stain epitope-specific CD8 T cells as described previously (4, 19).”
BackgroundSelf-citationB‐cell responses to HIV infection
Moir, S. L., & Fauci, A. S. (2017) · Immunological Reviews · doi:10.1111/imr.12502 · Cited by 171
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection
Wilson, J., Ogg, G. S., Allen, R. L., Davis, C., Shaunak, S., Downie, J., Dyer, W. B., Workman, C., Sullivan, J. S., McMichael, A. J., et al. (2000) · AIDS · doi:10.1097/00002030-200002180-00003 · Cited by 163
Self-citationCD1a autoreactive T cells recognize natural skin oils that function as headless antigens
de Jong, A., Cheng, T., Huang, S., Gras, S., Birkinshaw, R., Kasmar, A. G., van Rhijn, I., Peña-Cruz, V., Ruan, D. T., Altman, J. D., et al. (2013) · Nature Immunology · doi:10.1038/ni.2790 · Cited by 156
“Taking advantage of constructs previously designed for other CD1 proteins, we produced transmembrane-truncated, biotinylated CD1a proteins zippered to β -2 microglobulin ( β 2 M) with high yields in HEK293 cells 15,16 (Fig.”
BackgroundSelf-citationStarbeck-Miller, G. R., Xue, H., & Harty, J. T. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130901 · Cited by 161
“MHC class I tetramers (Kb) specific for OVA257–264 were prepared using published protocols (Altman et al., 1996; Busch et al., 1998).”
MethodMcMahon, C. W., Zajac, A. J., Jamieson, A. M., Corral, L. G., Hammer, G. E., Ahmed, R., & Raulet, D. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1444 · Cited by 162
Liu, L., Chahroudi, A., Silvestri, G., Wernett, M. E., Kaiser, W. J., Safrit, J. T., Komoriya, A., Altman, J. D., Packard, B. Z., & Feinberg, M. B. (2002) · Nature Medicine · doi:10.1038/nm0202-185 · Cited by 162
“More recently developed immunologic methods, including major histocompatibility complex (MHC)-tetramers, intracellular cytokine detection and ELISPOT assays, have greatly improved sensitivity to enumerate antigen-specific T cells; however, these newer methods do not assess the cytolytic function of antigen-specific CT…”
BackgroundSelf-citationFlow-cytometric analysis of rare antigen-specific T cells
Bacher, P., & Scheffold, A. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22317 · Cited by 155
“of peptide-MHC complexes to increase the relative binding avidity (22).”
BackgroundTrimble, L. A., & Lieberman, J. (1998) · Blood · doi:10.1182/blood.v91.2.585 · Cited by 161
Keller, A. M., Schildknecht, A., Xiao, Y., van den Broek, M. F., & Borst, J. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.10.009 · Cited by 160
“Flow Cytometry Tetrameric complexes of biotinylated murine MHC class I H-2D or H-2K heavy chain, b2 microglobulin, and relevant peptide were prepared as described (Altman et al., 1996), labeled with PE- or APC-conjugated streptavidin, and used in combination with CD8a mAb 53-6.”
MethodInfluentialHanekom, W. A., Hughes, J., Mavinkurve, M., Mendillo, M., Watkins, M., Gamieldien, H., Gelderbloem, S., Sidibana, M., Mansoor, N., Davids, V., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.010 · Cited by 160
Vitiligo puzzle: the pieces fall in place
Westerhof, W., & d’Ischia, M. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00399.x · Cited by 161
New flow cytometric assays for monitoring cell-mediated cytotoxicity
Zaritskaya, L., Shurin, M. R., Sayers, T. J., & Malyguine, A. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.49 · Cited by 156
Kaplan, D. E., Sugimoto, K., Newton, K. P., Valiga, M. E., Ikeda, F., Aytaman, A., Nunes, F. A., Lucey, M. R., Vance, B. A., Vonderheide, R. H., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.044 · Cited by 159
Immune markers and correlates of protection for vaccine induced immune responses
Thakur, A., Pedersen, L. E., & Jungersen, G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.049 · Cited by 164
Willing, A., Leach, O. A., Ufer, F., Attfield, K. E., Steinbach, K., Kursawe, N., Piédavent, M., & Friese, M. A. (2014) · European Journal of Immunology · doi:10.1002/eji.201344160 · Cited by 165
Chen, G., Shankar, P., Lange, C. G., Valdez, H., Skolnik, P. R., Wu, L., Manjunath, N., & Lieberman, J. (2001) · Blood · doi:10.1182/blood.v98.1.156 · Cited by 159
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
Barouch, D. H., Santra, S., Tenner‐Racz, K., Rácz, P., Kuroda, M. J., Schmitz, J. E., Jackson, S. S., Lifton, M. A., Freed, D., Perry, H. C., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.562 · Cited by 158
“Tetrameric H-2D complexes folded around the HIV-1 IIIB V3 loop optimal P18 epitope peptide (P18-I10 or RGPGRAFVTI) (36) were prepared and used to stain P18-specific CD8 T cells essentially as previously described (37, 38).”
MethodSelf-citationCD8+ T-cell selection, function, and death in the primary immune response in vivo
Callan, M. F. C., Fazou, C., Yang, H., Rostron, T., Poon, K., Hatton, C., & McMichael, A. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10590 · Cited by 158
“Soluble HLA/peptide tetrameric complexes were produced as described previously (4, 27).”
MethodSelf-citationLemckert, A. A. C., Sumida, S. M., Holterman, L., Vogels, R., Truitt, D. M., Lynch, D. M., Nanda, A., Ewald, B. A., Gorgone, D. A., Lifton, M. A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9694-9701.2005 · Cited by 158
Self-citationSabatino, J. J., Huang, J., Zhu, C., & Evavold, B. D. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101574 · Cited by 157
Meidenbauer, N., Marienhagen, J., Laumer, M., Vogl, S., Heymann, J., Andreesen, R., & Mackensen, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2161 · Cited by 157
The lymphoid liver: Considerations on pathways to autoimmune injury
Kita, H., de Water, J. V., Gershwin, M. E., & Mackay, I. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.22441 · Cited by 157
Sharkey, A., Gardner, L., Hiby, S. E., Farrell, L. E., Apps, R., Masters, L. M., Goodridge, J. P., Lathbury, L. J., Stewart, C. A., Verma, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.39 · Cited by 155
“HLA class I tetramers have been used to identify HLA-specific primary T cells in peripheral blood but the affinity of the KIR/HLA interaction is low and binding of HLA-C tetramers to primary NK cells has not been described (23).”
MethodChen, Y., Trofe, J., Gordon, J., Pasquier, R. D., Roy‐Chaudhury, P., Kuroda, M. J., Woodle, E. S., Khalili, K., & Koralnik, I. J. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3495-3505.2006 · Cited by 157
“plasmid HLA-A*0201/glyser/BirA substrate peptide (1) and refolded in vitro”
Bystander T cells in cancer immunology and therapy
Meier, S. L., Satpathy, A. T., & Wells, D. K. (2022) · Nature Cancer · doi:10.1038/s43018-022-00335-8 · Cited by 162
Ráki, M., Fallang, L.-E., Brottveit, M., Bergseng, E., Quarsten, H., Lundin, K. E. A., & Sollid, L. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608610104 · Cited by 156
Lissina, A., Ladell, K., Skowera, A., Clement, M., Edwards, E. S. J., Seggewiss, R., van den Berg, H. A., Emma Gostick, D., Gallagher, K., Jones, E., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.09.014 · Cited by 154
“their visualization, enumeration, phenotypic characterization and isolation from ex vivo samples (Altman et al., 1996; Chattopadhyay et al., 2006).”
BackgroundInfluentialOgg, G. S., Kostense, S., Klein, M. R., Jurriaans, S., Hamann, D., McMichael, A. J., & Miedema, F. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9153-9160.1999 · Cited by 156
Self-citationTopham, D. J., Castrucci, M. R., Wingo, F. S., Belz, G. T., & Doherty, P. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.6983 · Cited by 155
Tuohy, V. K., Yu, M., Yin, L., Kawczak, J. A., & Kinkel, R. P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1033 · Cited by 155
“The actual level of self-recognition plasticity may best be estimated by serial assessment of the autoreactive changes to overlapping peptides of several myelin proteins implicated in MS autoreactivity, such as PLP, MBP, and MOG, as well as by the incorporation of more sensitive assays such as the ELISPOT capable of p…”
BackgroundAntigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
Wölfl, M., & Greenberg, P. D. (2014) · Nature Protocols · doi:10.1038/nprot.2014.064 · Cited by 154
Chaux, P., Luiten, R. M., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V. E. A., Schultz, E. S., Cornelis, G. R., Boon, T., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2928 · Cited by 156
“One promising possibility, which nevertheless restricts the analysis to certain epitopes, is the use of a set of relevant peptides in combination with soluble HLA tetramers to label TCRs directly (50, 51).”
BackgroundAdoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay
Becker, C., Pohla, H., Frankenberger, B., Schüler, T., Assenmacher, M., Schendel, D. J., & Blankenstein, T. J. F. (2001) · Nature Medicine · doi:10.1038/nm1001-1159 · Cited by 154
Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols
Palmowski, M. J., Choi, E. M.-L., Hermans, I. F., Gilbert, S. C., Chen, J., Gileadi, U., Salio, M., Pel, A. V., Man, S., Bonin, E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4391 · Cited by 154
“Tetrameric A2/peptide complexes were synthesized as previously described (1).”
MethodEnvironmental cues dictate the fate of individual CD8+ T cells responding to infection
Plumlee, C. R., Sheridan, B., Cicek, B. B., & Lefrançois, L. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.014 · Cited by 160
“Flow Cytometry OVA- and N-specific T cells were stained with the H-2Kb tetramer containing the OVA peptide (SIINFEKL) and the H-2Kb tetramer containing the N peptide (RGYVYQGL) generated in our laboratory as previously described (Altman et al., 1996; Masopust et al., 2001).”
Bachmann, M. F., Gallimore, A., Linkert, S., Cerundolo, V., Lanzavecchia, A., Köpf, M., & Viola, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1521 · Cited by 153
“Soluble, biotinylated class I monomers, comprising the murine D b molecule, human b 2-microglobulin, and lymphocytic choriomeningitis virus (LCMV) 1 peptide p33, were generated as described previously (24, 25).”
MethodJoglekar, A. V., & Li, G. (2020) · Nature Methods · doi:10.1038/s41592-020-0867-z · Cited by 152
Bodinier, M., Peyrat, M., Tournay, C., Davodeau, F., Romagné, F., Bonneville, M., & Lang, F. (2000) · Nature Medicine · doi:10.1038/76292 · Cited by 152
Cavalieri, S., Cazzaniga, S., Geuna, M., Magnani, Z. I., Bordignon, C., Naldini, L., & Bonini, C. (2003) · Blood · doi:10.1182/blood-2003-01-0297 · Cited by 152
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
Bonhoeffer, S., Rembiszewski, M., Ortiz, G. M., & Nixon, D. F. (2000) · AIDS · doi:10.1097/00002030-200010200-00012 · Cited by 155
“Consequently, for the evaluation of the clinical data from STI trials it is crucial to obtain accurate quantitative measurements of the effector cell populations (both armed and memory effector cells) before, during, and after therapy, using assays such as the limiting dilution and/or chromium release assays [12,26] t…”
MethodThymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans
Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., Smedt, M. D., Guillaume, P., Ellefsen, K., Valmori, D., Líénard, D., Plum, J. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011658 · Cited by 156
Bakker, A., Hoppes, R., Linnemann, C., Toebes, M., Rodenko, B., Berkers, C. R., Hadrup, S. R., van Esch, W. J. E., Heemskerk, M. H. M., Ovaa, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709717105 · Cited by 151
Kuball, J. H. E., Hauptrock, B., Malina, V., Antunes, E., Voss, R.-H., Wölfl, M., Strong, R. K., Theobald, M., & Greenberg, P. D. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082487 · Cited by 151
The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1
Altfeld, M. A., & Rosenberg, E. S. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00103-5 · Cited by 151
Li, Y., & Yee, C. (2007) · Blood · doi:10.1182/blood-2007-05-089375 · Cited by 150
Dynamics of T Cell Responses in HIV Infection
Appay, V., Papagno, L., Spina, C. A., Hansasuta, P., King, A. S., Jones, L. E., Ogg, G. S., Little, S. J., McMichael, A. J., Richman, D. D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3660 · Cited by 152
“The HLA molecule H chain cDNAs were modified by substitution of the transmembrane and cytosolic regions with a sequence encoding the BirA biotinylation enzyme recognition site, as previously described (18).”
Self-citationImmunity to Listeria infection
Edelson, B. T., & Unanue, E. R. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00112-6 · Cited by 151
Geluk, A., van Meijgaarden, K. E., Franken, K. L. M. C., Drijfhout, J. W., D’Souza, S., Necker, A., Huygen, K., & Ottenhoff, T. H. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6463 · Cited by 151
“MHC/peptide tetramers were produced as described previously (32), but to abrogate CD8 binding, a mutated HLA-A*0201 heavy chain (denoted A2 m) was used, containing the mutation A2453V.”
MethodCD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
Peretz, Y., He, Z., Shi, Y., Yassine‐Diab, B., Goulet, J.-P., Bordi, R., Filali‐Mouhim, A., Loubert, J.-B., Far, M. E., Dupuy, F. P., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002840 · Cited by 150
“Plasma viral loads were measured with the Amplicor HIV-1 Monitor Ultrasensitive method with a limit of detection of 50 HIV-1 RNA copies/mL of plasma (Roche Diagnostics, Mississauga, Canada).”
MethodInfluentialA MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
Schultz, E. S., Lethé, B., Cambiaso, C. L., Snick, J. V., Chaux, P., Corthals, J., Heirman, C., Thielemans, K., Boon, T., & van der Bruggen, P. (2000) · PubMed · Cited by 150
Betts, M. R., Casazza, J. P., Patterson, B. A., Waldrop, S. L., Trigona, W. L., Fu, T., Kern, F., Picker, L. J., & Koup, R. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9144-9151.2000 · Cited by 150
“With the development of major histocompatibility complex (MHC) class I tetramer technology (1), studies have quantified the CD8(1) T-cell populations specific for individual HIV peptides and correlated these findings with various HIV disease parameters (21, 22).”
BackgroundAppay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 152
Arens, R., Schepers, K., Nolte, M. A., van Oosterwijk, M. F., van Lier, R. A. W., Schumacher, T. N., & van Oers, M. H. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031111 · Cited by 149
Lonchay, C., van der Bruggen, P., Connerotte, T., Hanagiri, T., Coulie, P. G., Colau, D., Lucas, S., Pel, A. V., Thielemans, K., van Baren, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405743101 · Cited by 149
Purbhoo, M. A., Boulter, J. M., Price, D. A., Vuidepot, A., Hourigan, C. S., Dunbar, P. R., Olson, K., Dawson, S. J., Phillips, R. E., Jakobsen, B. K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102498200 · Cited by 149
Self-citationDiscovery of rare cells from voluminous single cell expression data
Jindal, A., Gupta, P., Jayadeva, & Sengupta, D. (2018) · Nature Communications · doi:10.1038/s41467-018-07234-6 · Cited by 148
Masopust, D., Jiang, J. K., Shen, H., & Lefrançois, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2348 · Cited by 148
“MHC tetramers were produced essentially as previously described (14, 31).”
MethodPositive selection of MHC class Ib–restricted CD8+ T cells on hematopoietic cells
Urdahl, K. B., Sun, J. C.-Y., & Bevan, M. J. (2002) · Nature Immunology · doi:10.1038/ni814 · Cited by 148
“H-2K b tetramers bound to the OVA-derived peptide SIINFEKL were generated as describe”
MethodOligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific
Wilson, J., Ogg, G. S., Allen, R. L., Goulder, P., Kelleher, A. D., Sewell, A. K., O’Callaghan, C. A., Rowland‐Jones, S., Callan, M. F. C., & McMichael, A. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.785 · Cited by 148
“Tetrameric MHC–peptide complexes, which bind specifically to appropriate MHC–peptide-specific T cells (14) has been used to show that the large CD8 1 T cell expansions during the acute phase of EBV and lymphocytic choriomeningitis virus are largely antigen specific (15, 16).”
MethodSelf-citationProliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T Cells
van Leeuwen, E. M. M., Gamadia, L. E., Baars, P. A., Remmerswaal, E. B. M., ten Berge, I. J. M., & van Lier, R. A. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5838 · Cited by 147
Allen, T. M., Mothé, B. R., Sidney, J., Jing, P., Dzuris, J. L., Liebl, M. E., Vogel, T. U., O’Connor, D. H., Wang, X., Wussow, M. C., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.738-749.2001 · Cited by 147
“Gag_CM9 peptide complexes were constructed as previously described (3, 5).”
MethodSelf-citationCharacterization of two TCR transgenic mouse lines specific for herpes simplex virus
Mueller, S. N., Heath, W. R., McLain, J. D., Carbone, F., & Jones, C. M. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01071.x · Cited by 147
4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses
Dawicki, W., Bertram, E. M., Sharpe, A. H., & Watts, T. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5944 · Cited by 147
Dalod, M., Dupuis, M., Deschemin, J., Sicard, D., Salmon, D., Delfraissy, J., Venet, A., Sinet, M., & Guillet, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7108-7116.1999 · Cited by 147
“Total anti-HIV (X) and anti-EBV (1) responses calculated as the sum of the SFC numbers for all peptides recognized are also indicated.”
BackgroundResultDunne, P. J., Faint, J. M., Gudgeon, N. H., Fletcher, J. M., Plunkett, F. J., Soares, M. V. D., Hislop, A. D., Annels, N. E., Rickinson, A. B., Salmon, M., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0160 · Cited by 144
Wiley, J. A., Hogan, R. J., Woodland, D. L., & Harmsen, A. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3293 · Cited by 146
“These tetrameric complexes were synthesized by the Molecular Core Unit at the Trudeau Institute according to previously described procedures (14).”
MethodThe Liver: A Special Case in Transplantation Tolerance
Benseler, V., McCaughan, G. W., Schlitt, H. J., Bishop, G. A., Bowen, D. G., & Bertolino, P. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979471 · Cited by 146
Kupffer Cell-Dependent Hepatitis Occurs during Influenza Infection
Polakos, N. K., Cornejo, J. C., Murray, D. A., Wright, K. O., Treanor, J. J., Crispe, I. N., Topham, D. J., & Pierce, R. H. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050875 · Cited by 146
CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide
Miconnet, I., Koenig, S., Speiser, D. E., Krieg, A. Μ., Guillaume, P., Cerottini, J., & Romero, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1212 · Cited by 146
“5–1 10(6)) were prepared from peripheral blood, inguinal and paraaortic lymph nodes, and spleen from immunized mice and were stained with PE-coupled HLA-A2/ELA26–35 (ELAGIGILTV) tetramer synthesized as previously described (26) at doses indicated in the text in the presence of anti-FcR Ab (clone 2.”
MethodBouteiller, P. P. L., Barakonyi, A., Giustiniani, J., Lenfant, F., Marie‐Cardine, A., Aguerre‐Girr, M., Rabot, M., Hilgert, I., Mami‐Chouaib, F., Tabiasco, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012681099 · Cited by 146
Evolution of the T Cell Repertoire During Primary, Memory, and Recall Responses to Viral Infection
Blattman, J. N., Sourdive, D. J. D., Murali‐Krishna, K., Ahmed, R., & Altman, J. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6081 · Cited by 146
“MHC I tetramers were prepared and refolded with the appropriate peptide and b2-microglobulin as previously described (35).”
MethodSelf-citationClodi, K., Kliche, K.-O., Zhao, S., Weidner, D. A., Schenk, T., Consoli, U., Jiang, S., Snell, V., & Andreeff, M. (2000) · Cytometry · doi:10.1002/(sici)1097-0320(20000501)40:1 · Cited by 50
Revello, M. G., & Gerna, G. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.645 · Cited by 145
Haanen, J. B. A. G., Baars, A., Gomez, R., Weder, P., Smits, M., de Gruijl, T. D., Blomberg, B. M. E. V., Bloemena, E., Scheper, R. J., van Ham, S. M., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0018-5 · Cited by 152
“HLA class I tetrameric complexes were prepared as previously described with some modifications [17].”
MethodFunctional Subsets of Memory T Cells Identified by CCR7 Expression
Sallusto, F., Langenkamp, A., Geginat, J., & Lanzavecchia, A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-57276-0_21 · Cited by 145
Induction and Visualization of Mucosal Memory CD8 T Cells Following Systemic Virus Infection
Kim, S.-K., Schluns, K. S., & Lefrançois, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4125 · Cited by 145
Gandhi, R. T., & Walker, B. D. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104011 · Cited by 143
In vivo proliferation of naïve and memory influenza-specific CD8 + T cells
Flynn, K. J., Riberdy, J. M., Christensen, J. P., Altman, J. D., & Doherty, P. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8597 · Cited by 145
Self-citationBritten, C. M., Gouttefangeas, C., Welters, M. J. P., Pawelec, G., Koch, S. D., Ottensmeier, C. H. H., Mander, A., Walter, S., Paschen, A., Müller‐Berghaus, J., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0378-0 · Cited by 143
“The enzyme-linked immunospot (ELI-SPOT) assay [10, 11], staining with HLA-peptide multimers [ 12 ] and intracellular cytokine staining (ICS) [13, 14] are technologies used commonly for the monitoring of antigen-speciWc immune responses.”
Method
Metadata
- Authors
- Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M.
- Affiliations
- Stanford Medicine (US)
- John Radcliffe Hospital (GB)
- J. D. Altman and M. G. McHeyzer-Williams, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5428, USA.
- Howard Hughes Medical Institute (US)
- Corresponding author
- Davis, Mark M.
- ORCID
- Venue
- Science
- Published
- 1996-10-04
- Volume
- 274
- Issue
- 5284
- Pages
- 94-96
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2067069532
- Cited by
- 3,544
- References
- 39
- Citations by year
- 2026: 44 · 2025: 41 · 2024: 45 · 2023: 59 · 2022: 43 · 2021: 68 · 2020: 59 · 2019: 71 · 2018: 70 · 2017: 42 · 2016: 62 · 2015: 73 · 2014: 69 · 2013: 101 · 2012: 93
- FWCI
- 35.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- antigen-specific T cells, peptide-MHC tetramers, HLA-A2, cytotoxic T lymphocytes, cytotoxicity assay, T cell phenotyping, HIV infection, tumor-specific T cells, autoantigen-specific T cells
- MeSH terms
- Amino Acid Sequence, Epitopes, Antigens, Viral, Base Sequence, Cell Line, Coloring Agents, Flow Cytometry, HIV Seropositivity, Humans, Molecular Sequence Data, Peptide Fragments, Phenotype, RNA-Directed DNA Polymerase, T-Lymphocytes, Cytotoxic, Viral Matrix Proteins, Gene Products, gag, HLA-A2 Antigen, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review